Monogram Health has announced yet another contract extension with a major insurer, endorsing the two-year-old company’s worth in managing chronic kidney disease in Medicare Advantage patients.
Tech-enabled kidney disease management company Monogram Health scored a $160 million series B funding round backed by Humana. The funding round was led by TPG Capital, the private equity platform of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback